In addition, female APOE-e4 carriers are more likely to progress from mild cognitive impairment (MCI) to AD, have more brain atrophy and memory loss, and develop AD more frequently than age-matched males (Fleisher et al., 2008; Altmann et al., 2014; Sampedro et al., 2015). Here, APOE is linked to Cognitive impairment.